Hyderabad: Pharmaceuticals Export Promotion Council (PHARMEXCIL), the organization responsible for boosting internationa...
The Bangalore declaration of Council of Scientific and Industrial Research (CSIR) director's meeting, held during the ye...
Bangalore: Abexome Biosciences, an analytical solution provider to the biopharmaceutical industry and Bioneeds, a leadin...
Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Coop...
Bangalore: The GAVI Alliance signed a supply agreement with Biological E, India, according to which it will receive the ...
Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible...
India Innovation Fund (IIF) is a Securities and Exchange Board of India (SEBI) registered venture capital fund that inve...
Singapore: Alchemia provided an update on its marketed generic anti-coagulant product, fondaparinux, which was launched...
Mumbai: The US FDA's import alert at Quimicas Falcon de Mexico SA de C.V. (chemical manufacturing facility at Cuernavaca...
Singapore: Dr Kiran is the third woman to receive the Othmer Gold Medal, and the first Indian to make it to this prestig...
New Delhi: Indian pharmaceutical company Ranbaxy Laboratories is launching Absorica (Isotretinoin) capsules, a product ...
Singapore: Pall India entered into an exclusive India distribution agreement with a leading biosupplier, Spinchrom Life ...
Singapore: Foreign Direct Investment in drugs and pharmaceuticals industry in India was at $580 million during April-Oct...
Singapore: Ranbaxy's manufacturing unit in Toansa that had come under close regulatory scrutiny recently can now breathe...
Bangalore: TATAA Biocenter, the world's largest provider of hands-on trainingin qPCR and Sweden's most comprehensive di...
Singapore: Riddled with regulatory hurdles, many Indian pharmaceutical companies are increasingly setting up plants in t...
Singapore: The annual cases of cholera in the Caribbean Islands was reduced by 75 percent in the first quarter of 2014, ...
Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted...
